290 related articles for article (PubMed ID: 29958833)
1. Use of Breast Magnetic Resonance Imaging in Women Diagnosed With Atypical Ductal Hyperplasia at Core Needle Biopsy Helps Select Women for Surgical Excision.
Amitai Y; Menes T; Golan O
Can Assoc Radiol J; 2018 Aug; 69(3):240-247. PubMed ID: 29958833
[TBL] [Abstract][Full Text] [Related]
2. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
[TBL] [Abstract][Full Text] [Related]
3. Benign breast papillomas without atypia diagnosed with core needle biopsy: Outcome of surgical excision and imaging follow-up.
Polat DS; Knippa EE; Ganti R; Seiler SJ; Goudreau SH
Eur J Radiol; 2020 Oct; 131():109237. PubMed ID: 32905954
[TBL] [Abstract][Full Text] [Related]
4. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).
Tsuchiya K; Mori N; Schacht DV; Sheth D; Karczmar GS; Newstead GM; Abe H
J Magn Reson Imaging; 2017 Dec; 46(6):1738-1747. PubMed ID: 28295791
[TBL] [Abstract][Full Text] [Related]
5. High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.
Michaels AY; Ginter PS; Dodelzon K; Naunheim MR; Abbey GN
AJR Am J Roentgenol; 2021 Mar; 216(3):622-632. PubMed ID: 33439046
[No Abstract] [Full Text] [Related]
6. Radiologic and Pathologic Features Associated With Upgrade of Atypical Ductal Hyperplasia at Surgical Excision.
Williams KE; Amin A; Hill J; Walter C; Inciardi M; Gatewood J; Redick M; Wick J; Hunt S; Winblad O
Acad Radiol; 2019 Jul; 26(7):893-899. PubMed ID: 30318287
[TBL] [Abstract][Full Text] [Related]
7. Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy.
Ko E; Han W; Lee JW; Cho J; Kim EK; Jung SY; Kang MJ; Moon WK; Park IA; Kim SW; Kim KS; Lee ES; Min KH; Kim SW; Noh DY
Breast Cancer Res Treat; 2008 Nov; 112(1):189-95. PubMed ID: 18060577
[TBL] [Abstract][Full Text] [Related]
8. Breast MRI assists in decision-making for surgical excision of atypical ductal hyperplasia.
Johnson M; Stanczak B; Winblad OD; Amin AL
Surgery; 2023 Mar; 173(3):612-618. PubMed ID: 36202650
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy.
Chae BJ; Lee A; Song BJ; Jung SS
World J Surg Oncol; 2009 Oct; 7():77. PubMed ID: 19852801
[TBL] [Abstract][Full Text] [Related]
10. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
11. Atypical ductal hyperplasia: Clinicopathologic factors are not predictive of upgrade after excisional biopsy.
Sutton T; Farinola M; Johnson N; Garreau JR
Am J Surg; 2019 May; 217(5):848-850. PubMed ID: 30611396
[TBL] [Abstract][Full Text] [Related]
12. Atypical ductal hyperplasia on core needle biopsy: Development of a predictive model stratifying carcinoma upgrade risk on excision.
Salagean ED; Slodkowska E; Nofech-Mozes S; Hanna W; Parra-Herran C; Lu FI
Breast J; 2019 Jan; 25(1):56-61. PubMed ID: 30461131
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics.
Weinfurtner RJ; Patel B; Laronga C; Lee MC; Falcon SL; Mooney BP; Yue B; Drukteinis JS
Clin Breast Cancer; 2015 Jun; 15(3):234-9. PubMed ID: 25579460
[TBL] [Abstract][Full Text] [Related]
14. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
15. Upgrade rate of intraductal papilloma diagnosed on core needle biopsy in a single institution.
Lin LH; Ozerdem U; Cotzia P; Lee J; Chun J; Schnabel F; Darvishian F
Hum Pathol; 2021 Apr; 110():43-49. PubMed ID: 33159966
[TBL] [Abstract][Full Text] [Related]
16. Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.
Pawloski KR; Christian N; Knezevic A; Wen HY; Van Zee KJ; Morrow M; Tadros AB
Breast Cancer Res Treat; 2020 Dec; 184(3):873-880. PubMed ID: 32857242
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic upgrade of atypical ductal hyperplasia of the breast based on evaluation of histopathological features and calcification on core needle biopsy.
Chen LY; Hu J; Tsang JYS; Lee MA; Ni YB; Chan SK; Tse GMK
Histopathology; 2019 Sep; 75(3):320-328. PubMed ID: 31013355
[TBL] [Abstract][Full Text] [Related]
18. Flat epithelial atypia on core needle biopsy does not always mandate excisional biopsy.
Srour MK; Donovan C; Chung A; Harit A; Dadmanesh F; Giuliano AE; Amersi F
Breast J; 2020 Apr; 26(4):679-684. PubMed ID: 31562689
[TBL] [Abstract][Full Text] [Related]
19. The risk of upgrade for atypical ductal hyperplasia detected on magnetic resonance imaging-guided biopsy: a study of 100 cases from four academic institutions.
Khoury T; Li Z; Sanati S; Desouki MM; Chen X; Wang D; Liu S; Karabakhtsian R; Kumar P; Reig B
Histopathology; 2016 Apr; 68(5):713-21. PubMed ID: 26291517
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies - A 10-year retrospective study and review of the literature.
Co M; Kwong A; Shek T
Int J Surg; 2018 Jan; 49():27-31. PubMed ID: 29146271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
